Decline in Pharmaceutical Rep Numbers: Changing Practices of Doctors

The news for pharmaceutical reps is not valuable. Big pharma companies are merging, consolidating, and cutting back on what used to be a huge sales force.

Why is that?

Before you go off on the FDA, an industry-wide lack of innovation in research and development, or any other portion of the “supply” side of this equation, you may got to consider a simpler answer: the customer.

There’s a giant shift that’s accelerated over the last few years in how doctors view and interact with pharmaceutical reps, and in how they prefer to get their information on new drug treatments. In the old model, pharma reps visited doctors and dispensed freebies, samples, lunches and more to entice doctors to order from the company–a successful model that, combined with the exponential growth in pharma products, encouraged pharma companies to send out more and more reps until doctors were bombarded with increasingly frequent visits.   For example, at one time, Eli Lilly would double-, triple-, and quadruple-team targeted doctors.   In response, doctors have put more and more restrictions on visits by pharma reps, resulting in a sales-force ineffectiveness that’s caused leading pharma companies like Eli Lilly, Merck, and Pfizer to lay off sales reps by the thousands, with more to come.

Over-saturation is not the only issue, though.  Doctors often view pharma sales reps as salesmen, rather than experts.  There’s a subtle but critical distinction that makes a mountain of difference in how much value the revenue rep brings to the interaction for the doctor, which in turn affects both access and effectiveness.  This perceived lack of value is contributing to the disappearance of the traditional role of the pharmaceutical sales rep.

Are you a pharma sales rep?  Do you see these trends?  What else are you seeing?  And where do you see the role of the pharmaceutical sales rep going?

(If you’re a pharma rep who’s willing to move on, I help pharma reps move into clinical device, laboratory supply, and other clinical revenue roles as a career consultant in clinical sales.  In fact, here’s a link to an audio piece from a pharma rep who transitioned to surgical sales with some career coaching help. )

Article courtesy of  Peggy McKee - Owner / Senior Recruiter at the nationally
recognized medical and pharmaceutical sales recruiting team of PHC Consulting.
© Copyright 2008 PHC Consulting | All rights reserved

Related posts:

1. Laid-Off Pharma Reps: Get a Reference Even Though the Managers at Schering, Merck, or Wyeth Say You Can’t Have One It’s rough out there:  tens of thousands of pharma revenue…
2. “I just got laid off by a large Pharma company and would like to interview for the analytical capital equipment job selling you have advertised”. It seems that every week someone in our office has…
3. Cafe Pharma: The Web Equivalent of the Chaps’s Room Wall? Cafe Pharma (or Cafepharma) can be a great source of…

Decline in Pharma Rep Numbers: Changing Practices of Doctors